These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19000250)

  • 21. Evaluation of ifosfamide for treatment of various canine neoplasms.
    Rassnick KM; Frimberger AE; Wood CA; Williams LE; Cotter SM; Moore AS
    J Vet Intern Med; 2000; 14(3):271-6. PubMed ID: 10830540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dacarbazine as single-agent therapy for relapsed lymphoma in dogs.
    Griessmayr PC; Payne SE; Winter JE; Barber LG; Shofer FS
    J Vet Intern Med; 2009; 23(6):1227-31. PubMed ID: 19709354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open-label, dose-escalating phase I study of elsamitrucin (SPI 28090) in treatment of malignant solid tumors in dogs.
    Fiocchi SC; Selting KA; Rosenberg MP; Kolli P; Lenaz G; Henry C
    J Vet Intern Med; 2011; 25(4):897-902. PubMed ID: 21736623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label dose escalation study evaluating tolerability and safety of a single 5-days course of temozolomide in dogs with advanced cancer.
    Marconato L; Rohrer Bley C; Leone VF; Finotello R
    Vet Comp Oncol; 2020 Dec; 18(4):838-842. PubMed ID: 32510792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A toxicity study of low-dose rate half-body irradiation and chemotherapy in dogs with lymphoma.
    Lurie DM; Kent MS; Fry MM; Théon AP
    Vet Comp Oncol; 2008 Dec; 6(4):257-67. PubMed ID: 19178684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.
    Flory AB; Rassnick KM; Al-Sarraf R; Bailey DB; Balkman CE; Kiselow MA; Autio K
    J Vet Intern Med; 2008; 22(1):164-71. PubMed ID: 18289305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997).
    Thamm DH; Mauldin EA; Vail DM
    J Vet Intern Med; 1999; 13(5):491-7. PubMed ID: 10499735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
    Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
    J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
    Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
    Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosine arabinoside as a single agent for the induction of remission in canine lymphoma.
    Ruslander D; Moore AS; Gliatto JM; L'Heureux D; Cotter SM
    J Vet Intern Med; 1994; 8(4):299-301. PubMed ID: 7983628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
    Delva R; Pienkowski T; Tubiana N; Vanhoefer U; Longerey B; Douville I
    Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours.
    Trumel C; Bourgès-Abella N; Touron C; Lanore D; Geffré A; Diquelou A; Guelfi JF; Braun JP
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):275-9. PubMed ID: 16050908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of chemotherapeutic dose intensity and hematologic toxicity on first remission duration in dogs with lymphoma treated with a chemoradiotherapy protocol.
    Vaughan A; Johnson JL; Williams LE
    J Vet Intern Med; 2007; 21(6):1332-9. PubMed ID: 18196744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I dose-escalation study of nimustine in tumor-bearing dogs.
    Takahashi M; Goto-Koshino Y; Fukushima K; Kanemoto H; Nakashima K; Fujino Y; Ohno K; Endo Y; Tsujimoto H
    J Vet Med Sci; 2014 Jun; 76(6):895-9. PubMed ID: 24521794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases.
    Cooper M; Tsai X; Bennett P
    Vet Comp Oncol; 2009 Sep; 7(3):196-206. PubMed ID: 19691648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats.
    Krick EL; Cohen RB; Gregor TP; Salah PC; Sorenmo KU
    J Vet Intern Med; 2013; 27(1):134-40. PubMed ID: 23157371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.